Discriminatory value of plasma NfL, total tau, Aβ42, Aβ40, Aβ42/40 and α-syn as a single biomarker and as part of plasma biomarker panel in differentiating PDSs (PD and APD) from HC is presented in Table 2. This evidence concerns the gene MAPT and Parkinson disease.